FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:1152-1153 October 26, 1995 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Steiner, M.

To the Editor: The multicenter clinical trial of fluoxetine for the treatment of premenstrual mood symptoms reported by Steiner et al. (June 8 issue)¹ is good science but bad medicine. Cyclic changes in breast tenderness, fluid retention, nutrition, and emotional experiences are normal, are modulated by lifestyle, and are related to the emotional and social environment and culture. What evidence, other than help-seeking behavior, is there that the women in the study had pathologic depression requiring pharmacologic treatment?

Was an inhibitor of serotonin reuptake tested because disturbances of serotonin are caused by normal hormonal changes during the menstrual cycle or . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.